Siegfried Holding

Siegfried Holding, a Pharmaceutical Preparation Manufacturing company headquartered in Switzerland, reported its Scope 1, 2, and 3 greenhouse gas emissions for 2025 as approximately 689,000,000 kg CO2e. This includes about 52,000,000 kg CO2e from Scope 1, approximately 16,000,000 kg CO2e from market-based Scope 2, and around 621,000,000 kg CO2e from Scope 3.

Looking back, in 2024, the company's Scope 1 emissions were around 56,000,000 kg CO2e, and market-based Scope 2 emissions were approximately 15,000,000 kg CO2e. Scope 3 emissions in 2024 totalled about 583,000,000 kg CO2e. For 2023, Siegfried Holding reported Scope 1 emissions of approximately 56,000,000 kg CO2e, market-based Scope 2 emissions of around 19,000,000 kg CO2e, and Scope 3 emissions of about 559,000,000 kg CO2e. In 2022, their Scope 1 emissions were approximately 57,074,000 kg CO2e, and location-based Scope 2 emissions were around 14,250,000 kg CO2e, with Scope 3 emissions reaching about 462,005,000 kg CO2e.

Siegfried Holding has set several climate commitments. They aim to reduce their absolute Scope 1 and 2 GHG emissions by 66.89% by 2033, using 2020 as a baseline year. Additionally, they are committed to reducing absolute Scope 3 GHG emissions from fuel and energy-related activities, upstream transportation and distribution, and waste generated in operations by 32.5% by 2033, from a 2022 base year. The company also states a target for 85% of its suppliers by emissions covering purchased goods and services to have science-based targets by 2029.

For long-term goals, Siegfried Holding commits to achieving net-zero greenhouse gas emissions across its entire value chain by 2050. This includes reducing absolute Scope 1 and 2 GHG emissions by 90% by 2050 from a 2020 base year. Furthermore, they aim to reduce absolute Scope 3 GHG emissions from purchased goods and services, capital goods, upstream transportation and distribution, waste generated in operations, processing of sold products, and end-of-life treatment of sold products by 90% by 2050 from a 2022 base year. These targets have been approved by the Science Based Targets initiative (SBTi).